The evolving paradigm of tissue-specific metastasis.

Breast Cancer Res

Department of Anatomy and Cellular Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.

Published: March 2006

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413984PMC
http://dx.doi.org/10.1186/bcr1373DOI Listing

Publication Analysis

Top Keywords

evolving paradigm
4
paradigm tissue-specific
4
tissue-specific metastasis
4
evolving
1
tissue-specific
1
metastasis
1

Similar Publications

Melanoma is the fifth most common skin cancer in the UK, accounting for 4% of all new cancer cases, with a predicted 7% increase in incidence between 2014-35. In parallel, since the initial publication of the Melanoma NICE Guidelines in 2015, there has been a paradigm shift in the management of the disease, with the introduction of effective systemic therapies. These innovations have reshaped the management of melanoma throughout the patient journey, and improved clinical outcomes.

View Article and Find Full Text PDF

Purpose Of Review: This review addresses the current treatment paradigm and new advancements in the management of microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) esophagogastric cancer (EGC).

Recent Findings: While chemotherapy and surgery remain the cornerstone of EGC treatment, MSI-H/dMMR tumors harbor high tumor mutational burden and represent a subset of patients who benefit from immune checkpoint inhibitors (ICI). ICI has been incorporated in the front line setting with and without chemotherapy for advanced disease.

View Article and Find Full Text PDF

In the wild, stressors occur with varying likelihood throughout the day, leading animals to evolve plastic stress responses that exhibit circadian rhythmicity. In mammals, studies have revealed that the circadian plasticity of stress response may differ with age. However, such developmental effects have been largely overlooked in other vertebrate groups.

View Article and Find Full Text PDF

Current landscape of immunotherapy in esophageal cancer: a literature review.

J Thorac Dis

December 2024

Department of Surgery and Thoracic Surgery, Ascension Providence Hospital, Michigan State University College of Human Medicine, Southfield, MI, USA.

Background And Objective: Esophageal cancer has witnessed a significant shift in its epidemiology within the United States. Adenocarcinoma of the esophagus is now the fastest-growing solid malignancy, surpassing esophageal squamous cell carcinoma (ESCC) in frequency. There has been a concentrated effort to establish new therapies for dealing with this malignancy including immunotherapy in conjunction with surgery and radiotherapy.

View Article and Find Full Text PDF

Iris: A Next Generation Digital Pathology Rendering Engine.

J Pathol Inform

January 2025

University of Michigan Medical School, Department of Pathology, 2800 Plymouth Road, Ann Arbor, MI 48109-2800, USA.

Digital pathology is a tool of rapidly evolving importance within the discipline of pathology. Whole slide imaging promises numerous advantages; however, adoption is limited by challenges in ease of use and speed of high-quality image rendering relative to the simplicity and visual quality of glass slides. Herein, we introduce Iris, a new high-performance digital pathology rendering system.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!